Apr 6, 2009
N30 Pharma (N30) announced today the formation of their Science Advisory Board (SAB).
Mar 23, 2009
N30 Pharma (N30) announced today that Joseph Loscalzo, M.D., PhD., has joined the Board of Directors of the Company.
Oct 28, 2008
N30 Pharma (N30) announced today that it has completed a financing round and expanded its Board of Directors.
Oct 29, 2007
N30 Pharma (N30) today announced a licensing agreement with NitroMed (Nasdaq: NTMD) covering the respiratory use of a s-nitrosothiol drug candidate. Financial terms of the deal were not disclosed.